C.D.C. Advisers to Decide Who Should Receive New Covid Vaccines - The New York Times #geovax buff.ly/3ZcAsmA

Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors Learn more and register here. buff.ly/2HTba69

Innovators in #biotech come together #demycolton #healthcare #BioFuture2023 See the presentation live. buff.ly/3Lv6Gny

It's time for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023 buff.ly/3Lv6Gny

Learn about the company and their presentation time at this prestigious event for innovators. #biotech #demycolton #healthcare #BioFuture2023 buff.ly/3Lv6Gny

Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk - #immunocompromised #vaccine #manufacturing #MVA #immunotherapies $GOVX buff.ly/46RFHuP

buff.ly/3NyeQwl

buff.ly/3P5ni6P

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, will present at the 36th Annual Roth Conference in Dana Point, CA, on March 17-19, 2024. buff.ly/3TxsOlm

GeoVax Shares Are Making Big Moves: What's Going On? buff.ly/3X7GTbd

Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024 [email protected]

Registration Is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO. buff.ly/4dBid0E #mpox #vaccine $GOVX

#mpox buff.ly/3T4XMRo

GLP-1 Use and Costs Among US Adults With Type 2 Diabetes buff.ly/4etXRH3

We want to welcome GeoVax, Inc. to the ROTH Capital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at b2idigital.com/3rd-annual-rot… GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and

The One Thing Everyone Should Know About Fall COVID Vaccines #immunocompromised #feedly buff.ly/3ZjC3qT

GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius #healthcare #feedly buff.ly/4eyFYGg

GeoVax Labs, Inc. (GOVX-NASDAQ) has multiple trials advancing. Read more in this Just Released: 17-page Research Update. #immunocompromised #headandneckcancer $GOVX buff.ly/3AJwQkj

$GOVX working on addressing the shortage of available #MPOX vaccine. Update from CEO on the disease and the growing need here. buff.ly/3CIJSyW

#Vax #Anit-Vax #OpinionsCount buff.ly/4aEPnM2